Redox reaction of N,N′-phenylenebis-(salicylideneiminato)iron(III) with hypophosphorous acid in mixed aqueous medium

Komiyama M, Takeda N, Shigekawa H (1999) Hydrolysis of DNA and RNA by lanthanide ions: mechanistic studies leading to new applications. Chem Commun 16:1443–1451

Prema D, Wiznycia AV, Scott BMT, Hilborn J, Desper J, Levy CJ (2007) Dinuclear zinc(II) complexes of symmetric Schiff-base ligands with extended quinolone sidearms. Daltons Trans 42:4788–4796

Woldemariam GA, Mandal SS (2008) Iron(III)-salen damages DNA and induces apoptosis in human cell via mitochondrial pathway. J Inorg Biochem 102:740–747

Ansari KI, Grant JD, Woldemariam GA, Kasiri S, Mandal SS (2009) Iron(III)-salen complexes with less DNA cleavage activity exhibit more efficient apoptosis in MCF7 cells. Org Biomol Chem 7:926–932

Ansari IK, Sahba K, James DG, Mandal SS (2011) Fe(III) salen and salphen complexes induce caspase activation and apoptosis in human cells. J Biomol Screen 16:26–35

Czlapinski JL, Sheppard TL (2001) Nucleic acid template-directed assembly of metallosalen DNA conjugates. J Am Chem Soc 123:8618–8619

Doctrow SR, Huffman K, Marcus CB, Tocco G, Malfroy E, Adinolfi CA et al (2002) Salen-manganese complexes as catalytic scavengers of hydrogen peroxide and cytoprotective agents: structure-activity relationship studies. J Med Chem 45:4549–4558

Shrivastava HY, Devaraj SN, Nair BU (2004) A Schiff base complex of chromium(III): an efficient inhibitor for the pathogenic and invasive potential of Shigella dysenteriae. J Inorg Biochem 98:387–392

Routier S, Vezin H, Lamour E, Bernier JL, Catteau JP, Bailly C (1999) DNA cleavage by hydroxy-salicylidene-ethylendiamine-iron complexes. Nucleic Acids Res 27:4160–4166

Rokita SE, Burrows CJ (2001) Nickel- and cobalt-dependent oxidation and crosslinking of proteins. Met Ions Biol Syst 38:289–311

Cohen SM, Lippard SJ (2001) Cisplatin: from DNA damage to cancer chemotherapy. Prog Nucleic Acid Res Mol Biol 67:93–130

Barnes KR, Lippard SJ (2004) Cisplatin and related anticancer drugs: recent advances and insights. Met Ions Biol Syst 42:143

Ott I, Gust R (2007) Non platinum metal complexes as anticancer drugs. Archiv der Pharmazie (Weinheim) 340(3):117–126

Ibrahim I, Idris SO, Abdulkadir I, Onu AD (2019) Kinetics and mechanism of the redox reaction of N, N′-phenylenebis-(salicylideneiminato)iron(III) with oxalic acid in mixed aqueous medium. Transition Met Chem 44(3):269–273

Mehrotra RN (2013) Three oxyacids of phosphorus: tautomerism and oxidation mechanism. Eur Chem Bull 2(10):758–776

Greenwood NN, Earnshaw A (1997) Chemistry of the Elements, 2nd ed. Butterworth Heinemann. pp 461–464. ISBN 0080379419

Mohammed Y, Idris SO, Onu AD (2017) Kinetics and mechanism of the reduction of diaquotetrakis-(2,2’-bipyridine)- µ-oxodiruthenium(III) ion by hypophosphorous acid in acidicmedium. Transition Met Chem 42:323–329

Ayoko GA (1990) Oxidation of hypophosphorous and arsenious acids by 12-tungstocobaltate(III) ion in aqueous solution. Transition Met Chem 15:421–431

Yusuf UF, Iyun JF, Ayoko GA (2004) Oxidation of hypophosphorous acid by poly(pyridine)iron(III) complexes. ChemClass J 2:118–122

Hamza SA, Iyun JF, Idris SO (2012) Kinetics and mechanism of the redox reaction of toluidine blue and nitrite ions in aqueous acidic medium. Arch Appl Sci Res 4(1):10–18

Idris SO, Tanimu A, Iyun JF, Mohammed Y (2015) Kinetics and mechanism of malachite green oxidation by hypochlorite ion in aqueous acidic medium. Am Chem Sci J 5(2):185–193

Adetoro A, Iyun JF, Idris SO (2011) Kinetic approach to the mechanism of redox reaction of pyrocatechol violet and nitrite ion in aqueous hydrochloric acid. Res J Appl Sci Eng Technol 3(10):1159–1163

Atkins PW, de Paula J (2002) Physical chemistry, 7th edn. Oxford University Press, Oxford, p 962